Epie Boven

PROF.DR.

1997 …2023

Research activity per year

Network

Etto Eringa

Person: Academic

S. Mongera

Person: Administrative

Riekeld Scheper

Person: Academic

H.J. Guchelaar

  • Leiden University

External person

H. Gelderblom

  • Leiden University

External person

Vincent van der Noort

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital

External person

Henk-Jan Guchelaar

  • Leiden University Medical Center - LUMC
  • University of Amsterdam
  • Leiden University

External person

Mark Opdam

  • Netherlands Cancer Institute

External person

Sabine C. Linn

  • Netherlands Cancer Institute
  • Utrecht University
  • Antoni Van Leeuwenhoek Hospital

External person

Astrid A.M. Van Der Veldt

  • Erasmus Universiteit Rotterdam
  • Vrije Universiteit Amsterdam

External person

Aafke H Honkoop

  • Isala Clinics

External person

Joyce Sanders

  • Antoni Van Leeuwenhoek Hospital
  • Netherlands Cancer Institute

External person

J.A.M. Wessels

  • Netherlands Organisation for Applied Scientific Research

External person

Jos Jonkers

  • Netherlands Cancer Institute

External person

Jesse J. Swen

  • National Institute of Public Health and the Environment
  • Leiden University

External person

Cristina Rodríguez-Antona

  • Biomedical Network on Rare Diseases (CIBERER)
  • Instituto de Salud Carlos III
  • University of Barcelona
  • University of Girona

External person

Agnes Jager

  • Erasmus MC
  • Erasmus Universiteit Rotterdam

External person

R. Jones

  • MS Bioworks LLC

External person

Stefan Sleijfer

  • Erasmus Universiteit Rotterdam
  • Center for Personalized Cancer Treatment

External person

Michel van Kruchten

  • University of Groningen

External person

Ron H. J. Mathijssen

  • Erasmus Universiteit Rotterdam

External person

Egbert Oosterwijk

  • Department of Obstetrics and Gynaecology
  • Radboud University Nijmegen

External person

Elisabeth G. E. de Vries

  • University Medical Center Groningen
  • University of Groningen

External person

A. Jager

  • Erasmus Universiteit Rotterdam
  • University of Amsterdam

External person

Carolina P Schröder

  • University of Groningen

External person

Hennie M.M. Schlüper

  • VU Medisch Centrum

External person

Andor W. J. M. Glaudemans

  • University of Groningen

External person

Tahar van der Straaten

  • Leiden University Medical Center - LUMC
  • Leiden University

External person

Karin J. Beelen

  • Netherlands Cancer Institute
  • Reinier de Graaf Groep

External person

K. Hoekman

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Clasina M Venema

  • University of Groningen

External person

Frank B. Van Gog

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

W. Boogerd

  • Antoni Van Leeuwenhoek Hospital
  • Vrije Universiteit Amsterdam

External person

Max Roessler

  • CESAR Central Office, Vienna, Austria

External person

Bert van der Vegt

  • University of Groningen

External person

Els Kievit

  • VU Medisch Centrum

External person

Sven Rottenberg

  • University of Bern
  • Netherlands Cancer Institute

External person

Lambertus A. L. M. Kiemeney

  • Department of Obstetrics and Gynaecology
  • Radboud University Nijmegen

External person

G.C. de Gast

  • VU University Medical Hospital
  • Utrecht University

External person

J. Wagstaff

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam
  • Maastricht University

External person

Marius T. Radu

  • Carol Davila University of Medicine and Pharmacy

External person

Kerstin Junker

  • Saarland University

External person

H. van Tinteren

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital
  • Comprehensive Cancer Centre the Netherlands
  • Vrije Universiteit Amsterdam

External person

Hidde J Haisma

  • Free University Hospital
  • Vrije Universiteit Amsterdam

External person

X. Liu

  • University of Warwick
  • Columbia University

External person

Daniel Castellano

  • Oncology Department, Madrid, Spain

External person

Asgerdur Sverrisdottir

  • Landspitali University Hospital

External person

Yuval Malka

  • Oncode Institute
  • Netherlands Cancer Institute

External person

Petra van der Groep

  • Johns Hopkins University

External person

Karel K. M. Koudijs

  • Leiden University Medical Centre

External person

Monique E M Bos

  • Reinier de Graaf Groep
  • Erasmus Universiteit Rotterdam

External person

John W M Martens

  • Erasmus Universiteit Rotterdam
  • Wageningen University & Research
  • Center for Personalized Cancer Treatment

External person

Liesbeth Hoekman

  • Netherlands Cancer Institute

External person

Patrik Weder

  • Cantonal Hospital St. Gallen
  • Swiss Group for Clinical Cancer Research

External person

Julien Grenier

  • Institut Sainte Catherine

External person

Jean-Christophe Thery

  • Centre Georges-François Leclerc

External person

Miranda Verschraagen

  • Vrije Universiteit Amsterdam

External person

Bjørn Siteur

  • Netherlands Cancer Institute

External person

K. Bosscha

  • Jeroen Bosch Ziekenhuis
  • University of Groningen

External person

Dirk Mangnus

  • Vrije Universiteit Amsterdam

External person

Anne Cambon-Thomsen

  • Université Paul Sabatier Toulouse III

External person

Jinhyuk Bhin

  • Oncode Institute
  • Netherlands Cancer Institute

External person

G. Giaccone

  • Vrije Universiteit Amsterdam

External person

Karin Ribi

  • International Breast Cancer Study Group

External person

Kristin Alexiusdottir

  • Landspitali University Hospital

External person

J.N.H. Timmer-Bonte

  • Alexander Monro Ziekenhuis

External person

Hanne Hawle

  • Swiss Group for Clinical Cancer Research

External person

F. Dalenc

  • Institut Claudius Regaud

External person

Alphons H. H. Bongaerts

  • University of Groningen

External person

Maurice P H M Jansen

  • Erasmus Universiteit Rotterdam
  • Ziekenhuis Gelderse Vallei

External person

Nathaniel I. Martin

  • Leiden University

External person

Reuven Agami

  • Netherlands Cancer Institute
  • Rotterdam University of Applied Sciences
  • Erasmus Universiteit Rotterdam

External person

Marieke van de Ven

  • Mouse Clinic for Cancer and Aging Research (MCCA), Amsterdam, Netherlands

External person

Kasper van de Born

  • Department of 1Medical Oncology, 1081 HV Amsterdam, Netherlands

External person

B. Thürlimann

  • Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland

External person

Anne Warren

  • Addenbrooke's Hospital

External person

M.J.C. van der Sangen

  • Catharina Hospital

External person

Jos H. Beijnen

  • Netherlands Cancer Institute
  • Slotervaart Hospital
  • Utrecht University
  • Antoni Van Leeuwenhoek Hospital
  • Princess Máxima Center for Pediatric Oncology

External person

Harm Van Tinteren

  • Netherlands Cancer Institute
  • Comprehensive Cancer Centre the Netherlands
  • Antoni Van Leeuwenhoek Hospital
  • KU Leuven

External person

Laurence Vanlemmens

  • Centre Oscar Lambret

External person

Bart de Valk

  • Spaarne Gasthuis

External person

G. Motta

  • Erasmus MC Cancer Institute
  • Mediterranean Institute of Oncology
  • University of Catania

External person

Henrica C.W. de Vet

  • Vrije Universiteit Amsterdam
  • University of Groningen
  • University of Amsterdam
  • Amsterdam UMC

External person

Qiyu Li

  • Swiss Group for Clinical Cancer Research

External person

Xiaoyan Liu

  • Leiden University Medical Centre
  • Shandong University

External person

Dennis D. G. C. Peters

  • Core Facility Molecular Pathology and Biobanking, Amsterdam, Netherlands

External person

O. van Tellingen

  • Netherlands Cancer Institute

External person

S. Oosting

  • University of Groningen

External person

Jens Huober

  • Ulm University

External person

Chiara S. Brambillasca

  • Netherlands Cancer Institute
  • Oncode Institute

External person

Onno Bleijerveld

  • Netherlands Cancer Institute

External person

J. van Ark-Otte

  • Vrije Universiteit Amsterdam

External person

Brian I. Rini

  • Cleveland Clinic Foundation

External person

Richard R. de Haas

  • Vrije Universiteit Amsterdam

External person

Andreas Müller

  • Cantonal Hospital Winterthur

External person

Johanneke E. A. Portielje

  • Haga Ziekenhuis
  • Leiden University

External person

Ida V.D. Meulen-Muileman

  • Vrije Universiteit Amsterdam

External person

H.J. Bloemendal

  • Meander Medical Center

External person

Wilbert Zwart

  • Netherlands Cancer Institute
  • Eindhoven University of Technology

External person

Timothy Eisen

  • University of Cambridge

External person

A Cervantes

  • University of Valencia
  • Instituto de Salud Carlos III

External person

John Martens

  • Department of Medical Oncology, Rotterdam, Netherlands

External person

Julia Yemelyanenko

  • Netherlands Cancer Institute
  • Oncode Institute

External person

Christelle Levy

  • François Baclesse Center

External person

J.J. Beckeringh

  • Westwijk Pharmaceutics BV
  • Utrecht University
  • Cyberpharm Science Office
  • University of Amsterdam

External person

S. Kaye

  • Princeton University

External person

Carolien H. Smorenburg

  • Antoni Van Leeuwenhoek Hospital

External person

Marie-Aline Gérard

  • Swiss Group for Clinical Cancer Research

External person

S. verine Guiu

  • Centre régional de lutte du cancer Val d'Aurelle

External person

Achim Fritsch

  • University of Bonn

External person

Sabine Linn

  • Antoni Van Leeuwenhoek Hospital
  • Utrecht University

External person

Karianne Schuurman

  • Netherlands Cancer Institute

External person

Tim Eisen

  • Addenbrooke's Hospital

External person

Charlotte N. Frederiks

  • St. Antonius Ziekenhuis
  • Utrecht University

External person

John B. Haanen

  • Netherlands Cancer Institute

External person

Etienne Brain

  • Institut Curie

External person

Stefan Bohringer

  • Leiden University Medical Centre

External person

A.J. ten Tije

  • Amphia Hospital

External person

Justin Sprengers

  • Netherlands Cancer Institute

External person

Aart Beeker

  • Spaarne Gasthuis

External person

Manouk K. Bos

  • University of Amsterdam

External person

Xue Chao

  • Netherlands Cancer Institute
  • Oncode Institute

External person

Maarten Altelaar

  • Proteomics Facility, 1066 Amsterdam, Netherlands
  • Biomolecular Mass Spectrometry and Proteomics, 3584 Utrecht, Netherlands

External person

Tsuneharu Miki

  • Kyoto Prefectural University of Medicine

External person

C. M. Beaufort

  • Erasmus MC Cancer Institute

External person

Erik F de Vries

  • University of Groningen

External person

Hans Gelderblom

  • Leiden University Medical Center - LUMC
  • Leiden University
  • Erasmus Universiteit Rotterdam

External person

Matthijs J. Van Haren

  • Leiden University

External person

S. Horenblas

  • Antoni Van Leeuwenhoek Hospital

External person

W.M. Smit

  • Onze Lieve Vrouwe Gasthui

External person

B. Zwart

  • Sanquin Blood Supply Foundation

External person

Joan van den Bosch

  • Albert Schweitzer Ziekenhuis

External person

Fumiya Hongo

  • Kyoto Prefectural University of Medicine

External person

Daniel Zingg

  • Netherlands Cancer Institute
  • Oncode Institute

External person

Lodewyk Frederik Ary Wessels

  • Netherlands Cancer Institute
  • Delft University of Technology

External person

Erik F J de Vries

  • University Medical Center Groningen
  • University of Groningen

External person

Daniel Dietrich

  • Swiss Group for Clinical Cancer Research

External person

M. Opdam

  • Netherlands Cancer Institute

External person

Aude-Marie Savoye

  • Centre Georges-François Leclerc

External person

Yuana Yuana

  • Vrije Universiteit Amsterdam

External person

D.S.W. Tan

  • National Cancer Centre

External person

Jesus García-Donas

  • Medical Oncology, Madrid, Spain

External person

Michiel Nieuwenhuis

  • Vrije Universiteit Amsterdam

External person

J. C. A. Helmijr

  • Erasmus MC Cancer Institute

External person

Rob Ruijtenbeek

  • Pamgene's Hertogenbosch
  • PamGene International BV

External person

Valentin Ambert

  • Carol Davila University of Medicine and Pharmacy

External person

Jesus Garcia Donas

  • Medical Oncology

External person

Herve Bonnefoi

  • Centre Georges-François Leclerc

External person

Geke Ap Hospers

  • University of Groningen

External person

W.C.J. Hop

  • Erasmus Universiteit Rotterdam

External person

Stefano Annunziato

  • Division of Molecular Pathology, Amsterdam, Netherlands

External person

Geke A P Hospers

  • University Medical Center Groningen
  • University of Groningen

External person

V.C.G. Tjan-Heijnen

  • Maastricht University Medical Center
  • Maastricht University
  • Maastricht UMC

External person

Ulrich Jaehde

  • University of Bonn

External person

Roberto Pili

  • Indiana University-Purdue University Indianapolis

External person